Nicholas Willumsen

Director & Head of Oncology Nordic Bioscience A/S

Seminars

Tuesday 4th November 2025
Leveraging Tumor Fibrosis Biomarkers to Accelerate ADC Development
2:30 pm
  • Quantifying tumor fibrosis to optimize ADC patient selection and stratification to improve response rates
  • Measuring dynamic tumor extracellular matrix remodeling to capture proteolytic activities (cathepsins, metalloprotease etc.)
  • Applying to ADC development through enhancing target engagement assessment, biomarker-driven trial design, and translational decision-making
  • Linking extracellular matrix dynamics to payload delivery, target accessibility, and patient stratification and monitoring strategies
Nicholas Willumsen- 16th World ADC San Diego